Newspaper publication on February 07, 2026, with respect to the unaudited financial results for the quarter and nine months ended December 31, 2025
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Solara Active Pharma Sciences has published its unaudited financial results for the quarter and nine months ended December 31, 2025 in a newspaper on February 7, 2026. This is a routine regulatory disclosure made under SEBI's Listing Obligations, where listed companies are required to publish their quarterly financial outcomes in at least one English and one vernacular newspaper. The actual numbers from the results are not included in the headline, but investors can find them in the detailed financial results already filed with the exchanges.
This is a standard compliance filing with no direct impact on the stock price. Investors should look at the underlying Q3 results for actual revenue, profit, and margin performance to assess any meaningful impact.